Two Studies Find Link Between Sleep Apnea And Asthma, Alzheimer’s – RedOrbit


RedOrbit

Two Studies Find Link Between Sleep Apnea And Asthma, Alzheimer's
RedOrbit
Two new studies to be presented at the American Thoracic Society 2013 International Conference in Philadelphia this week found strong associations between sleep apnea and other disorders. In one study, published in the American Journal of Respiratory
Researchers identify a potential new risk for sleep apnea: Asthma – EurekAlert!EurekAlert (press release)
Asthma Bad For a Good Night's SleepdailyRx
Study Reports Sleep Apnea Tied to AsthmaCounsel & Heal
Medical Daily
all 8 news articles »

View full post on asthma – Google News

Hay Fever and Asthma as Markers of Atopic Immune Response and Risk of Colorectal Cancer in Three Large Cohort Studies.

Related Articles

Hay Fever and Asthma as Markers of Atopic Immune Response and Risk of Colorectal Cancer in Three Large Cohort Studies.

Cancer Epidemiol Biomarkers Prev. 2013 Mar 19;

Authors: Jacobs EJ, Gapstur SM, Newton CC, Turner MC, Campbell PT

Abstract
BACKGROUND: In a previous analysis of 12 cancers in the Cancer Prevention Study II (CPS-II) cohort including follow-up from 1982-2000, having both hay fever and asthma was associated with lower colorectal cancer mortality. The combination of these allergic conditions may be a marker for allergy-related immune responses that could inhibit colorectal carcinogenesis.METHODS: We examined the association of having both hay fever and asthma with colorectal cancer mortality among 1,023,191 participants in CPS-I, followed from 1959-1972, and 1,102,092 participants in CPS-II, now followed from 1982-2008. We also examined associations with colorectal cancer incidence among 174,917 participants in the CPS-II Nutrition Cohort, a subgroup of CPS-II followed from 1992-2007. During the follow-up, there were 5,644 colorectal cancer deaths in CPS-I, 13,558 colorectal cancer deaths in CPS-II, and 3,365 incident colorectal cancer cases in the CPS-II Nutrition Cohort. Cox proportional hazards regression was used to calculate multivariable-adjusted relative risks (RR) and 95% confidence intervals (CI).RESULTS: RRs for colorectal cancer mortality associated with having both asthma and hay fever, compared with neither condition, were 0.90 (95% CI, 0.74-1.09) in CPS-I, 0.79 (95% CI, 0.69-0.91) in CPS-II, and 0.83 (95% CI, 0.74-0.92) when results from both cohorts were combined in a meta-analysis. The corresponding RR for colorectal cancer incidence in the CPS-II Nutrition Cohort was 0.90 (95% CI, 0.71-1.14).CONCLUSION: These results support an association between having both hay fever and asthma and modestly lower colorectal cancer mortality.Impact: Research examining other potential markers of allergy-related immune response in relation to colorectal cancer is warranted. Cancer Epidemiol Biomarkers Prev; 22(4); 1-9. ©2013 AACR.

PMID: 23513040 [PubMed – as supplied by publisher]

View full post on pubmed: asthma

LA BioMed’s Dr. Virender Rehan studies maternal nicotine’s effects on unborn … – Science Codex

LA BioMed's Dr. Virender Rehan studies maternal nicotine's effects on unborn
Science Codex
LOS ANGELES (Oct. 15, 2012) – Currently, there are approximately 25 million people in the United States who suffer from the lifelong effects of asthma – wheezing, breathlessness, tightness in the chest, coughing – and the numbers are rising each year.

and more »

View full post on asthma – Google News

Rigel Initiates Phase 2 Clinical Studies with R343 for Asthma and R333 for … – Sacramento Bee

Rigel Initiates Phase 2 Clinical Studies with R343 for Asthma and R333 for
Sacramento Bee
SOUTH SAN FRANCISCO, Calif., Sept. 5, 2012 — /PRNewswire/ — Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that it has commenced Phase 2 clinical studies with two of the company's most advanced proprietary therapeutic product
Rigel commences R343 and R333 Phase 2 studies in allergic asthma, discoid News-Medical.net
Leerink Swann Starts Rigel Pharmaceuticals (RIGL) at Outperform; Top Biotech StreetInsider.com (subscription)

all 4 news articles »

View full post on asthma – Google News

Rigel Initiates Phase 2 Clinical Studies with R343 for Asthma and R333 for … – The Herald | HeraldOnline.com

Rigel Initiates Phase 2 Clinical Studies with R343 for Asthma and R333 for
The Herald | HeraldOnline.com
SOUTH SAN FRANCISCO, Calif., Sept. 5, 2012 — /PRNewswire/ — Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that it has commenced Phase 2 clinical studies with two of the company's most advanced proprietary therapeutic product
Rigel Pharma (RIGL) Starts Clinical Studies For Asthma, Discoid LupusiStockAnalyst
Rigel Begins Trial With Advanced Proprietary Therapeutic Product CandidatesNASDAQ

all 13 news articles »

View full post on asthma – Google News

Three Pulmatrix PUR118 clinical studies on COPD, asthma to be presented at … – News-Medical.net

Three Pulmatrix PUR118 clinical studies on COPD, asthma to be presented at
News-Medical.net
Pulmatrix, Inc., a clinical stage biotechnology company creating novel inhaled therapeutics, announced today that three posters on its lead iCALM™ therapeutic, the first treatment developed utilizing its iSPERSE™ inhaled drug platform, will be

and more »

View full post on asthma – Google News